Financial statements Pure Biologics

Cash flow statement of Pure Biologics

Company age:
Age:
7 y. 11 m. 2 d.
Share capital:
Share capital:
102 600 PLN

Cash inflows of PURE BIOLOGICS

Year
2018
2019
Net cash from operating expenses -2 487 906,13 5 334 578,60
Net cash flow from investing activities -162 152,23 -161 915,64
Net cash flow from financial activities 2 579 895,43 8 552 569,04
Total net cash flow -70 162,93 13 725 232,00
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.